Otsuka Pakistan Limited has resumed production at its manufacturing facility following the completion of planned annual ...

Police investigate medical negligence after two dialysis patients died at Haripad hospital, raising concerns about safety ...

The Indore contaminated water crisis, where sewage leaked into drinking water, sickening hundreds and causing deaths, ...

BioArctic AB's (publ) partner Eisai announced today that the Biologics License Application (BLA) for the subcutaneous formulation (subcutaneous autoinjector: SC-AI) of Leqembi (lecanemab) for ...

Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...

Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical technologies, ...

The approval of subcutaneous amivantamab allows physicians flexibility in offering treatment for non–small cell lung cancer.

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the Biologics License Application (BLA) for the subcutaneous formulation ...

Health department investigates deaths of two dialysis patients at Haripad hospital, closing the unit for 15 days for evaluation.

Being diagnosed with high blood pressure is important, as it is one of the biggest risk factors for heart attacks and strokes ...

Interim data from 14 patients with progressive lung cancers in dose-escalation cohorts of systemically administered Olvi-Vec-primed ...

A phase 1 study to evaluate safety, tolerability, bioavailability, pharmacokinetics, and weight loss of GLP-1/GLP-2 dual agonist, PG-102, ...